7th Annual Conference Of The British HIV Association [BHIVA]


27 – 29 April 2001, The Hove Centre, Brighton


Print this article
[TITLE:] ACUTE ONSET LACTIC ACIDOSIS AND PANCREATITIS IN THE THIRD TRIMESTER OF PREGNANCY AS A RESULT OF ANTIRETROVIRAL MEDICATION.

[AUTHOR(S):] L Sarner, A Fakoya
The Greenway Centre, Newham General Hospital, London, UK

BHIVA Conf 2001 Apr 27-29;7:O23


INTRODUCTION: Mitochondrial toxicity is now well recognised as a result of nucleoside analogue therapy. We present two cases of acute lactic acidosis in the third trimester of pregnancy.

CASE 1: A 30-year-old woman (CD4 count 450 cells/µl, viral load <50 HIV-1 RNA copies/ml) taking didanosine, stavudine and nevirapine for 3 years, presented in the 37th week of pregnancy with an acute onset of severe lactic acidosis (lactate 22.5 mmol/l), resulting in maternal and foetal death.

CASE 2: A 31-year-old woman (CD4 count 650 cells/µl, viral load <50 HIV-1 RNA copies/ml) taking didanosine, stavudine and nevirapine for 2 years presented in the 33rd week of pregnancy with acute-onset lactic acidosis (lactate 6.8 mmol/l) and pancreatitis (amylase 1990 IU/l).

TREATMENT: Both cases were managed supportively and given riboflavin, resulting in a full recovery and delivery of a live infant in the second case.

DISCUSSION: Studies show that late pregnancy may be associated with low riboflavin levels. This, in combination with mitochondrial toxicity, may precipitate sudden-onset severe lactic acidosis. Heightened awareness and further evaluation of risk factors and screening tools is required.

PRESENTING AUTHOR: L Sarner

Download Presentation

010427
O23

Copyright © 2001 - British HIV Association (BHIVA) Reproduction of this abstract (other than one copy for personal reference) must be cleared through the BHIVA Organising Secretariat 1 Mountview Court, 310 Friern Barnet Lane, London N20 0LD